Longmen Capital
Overview
Longmen Capital is a private equity firm based in Shenzhen, Guangdong, China, focusing on investments in the medical sector. The firm was founded in 2017 and has been actively investing in various healthcare-related companies since its inception. The firm's investment strategy targets growth and late-stage companies within the healthcare industry, including medical devices and biotechnology sectors. Longmen Capital primarily operates within China, aiming to support the development and expansion of medical enterprises across the country. With a dedicated team and a clear focus on the medical sector, Longmen Capital has established itself as a significant player in China's private equity landscape, contributing to the advancement of the healthcare industry through strategic investments and partnerships.
Investment Focus
- Established medical companies with growth potential
- Companies seeking expansion capital
- Businesses in need of strategic guidance in the healthcare sector
Portfolio Companies
Reach Longmen Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Longmen Capital
What sectors does Longmen Capital invest in?
Longmen Capital invests in Healthcare, Medical Devices and Biotechnology, and is based in Guangdong, China. Longmen Capital is listed as a private equity in the ConnectSafely investor database.
What stage does Longmen Capital invest at?
Longmen Capital backs companies at Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Longmen Capital invest in?
Longmen Capital invests across China.
What companies has Longmen Capital invested in?
Longmen Capital's portfolio includes Degron Therapeutics.
Last updated · Source: ConnectSafely investor database
